82 related articles for article (PubMed ID: 6902691)
1. [Prognosis in patients with cerebral ischemia treated with short term anticoagulant therapy -- a controlled trial (author's transl)].
Gallhofer B; Ladurner G; Lechner H
Fortschr Neurol Psychiatr Grenzgeb; 1980 Aug; 48(8):409-14. PubMed ID: 6902691
[No Abstract] [Full Text] [Related]
2. Prognosis of prophylactic anticoagulant treatment in ischaemic stroke.
Gallhofer B; Ladurner G; Lechner H
Eur Neurol; 1979; 18(3):145-8. PubMed ID: 477686
[TBL] [Abstract][Full Text] [Related]
3. [Treatment with anticoagulants in glomerulonephritis (author's transl)].
Girndt J
Med Klin; 1979 Nov; 74(47):1767-71. PubMed ID: 522818
[TBL] [Abstract][Full Text] [Related]
4. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
Petersen PB; Husted S; Mortensen A; Andreasen F
Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
[TBL] [Abstract][Full Text] [Related]
5. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
6. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
Angelkort B
Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
[TBL] [Abstract][Full Text] [Related]
7. [Remote development of transient ischemic attack, reversible ischemic neurologic deficit and infarct with minimum residual damage. Prospective study of 149 patients treated medically].
Calandre L; Gomara S; Ozaita G; Bermejo F
Med Clin (Barc); 1987 Sep; 89(7):265-8. PubMed ID: 3683002
[No Abstract] [Full Text] [Related]
8. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
Breddin K; Loew D; Lechner K; Uberla K; Walter E
Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
[No Abstract] [Full Text] [Related]
9. [Long-term anticoagulant therapy for transient ischemic attack and cerebral infarct with minor symptoms].
Müller R; Olsson JE
Lakartidningen; 1977 Nov; 74(45):3973-8. PubMed ID: 926938
[No Abstract] [Full Text] [Related]
10. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
Walter E; Weber E; Loew D
Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
[No Abstract] [Full Text] [Related]
11. [How should anticoagulants be used in recurrent, ischemic and hemorrhagic brain infarctions?].
Leschke M; Klimek W
Dtsch Med Wochenschr; 2003 Oct; 128(42):2213-4. PubMed ID: 14562222
[No Abstract] [Full Text] [Related]
12. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
Harenberg J; Haas R; Zimmermann R
Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of rifampicin with phenprocoumon (author's transl)].
Held H
Dtsch Med Wochenschr; 1979 Sep; 104(37):1311-4. PubMed ID: 477551
[TBL] [Abstract][Full Text] [Related]
14. [Ticlopidine. Secondary prevention of ischemic cerebral infarct].
Diener HC; Weiller C
Internist (Berl); 1993 Dec; 34(12):1150-5. PubMed ID: 8106211
[No Abstract] [Full Text] [Related]
15. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
Breddin HK; Uberla KK
Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
[No Abstract] [Full Text] [Related]
16. [Secondary prevention of recurrent transient ischemic attacks].
Pizzulli L; Lüderitz B
Internist (Berl); 1998 Apr; 39(4):411-2. PubMed ID: 9599754
[No Abstract] [Full Text] [Related]
17. [A prospective study on the clinical features and prognosis of transient cerebral ischemic attacks (author's transl)].
Tsuda Y; Nukada T; Yoneda S; Tanaka K; Ashida K; Imaizumi M
No To Shinkei; 1980 Oct; 32(10):1015-24. PubMed ID: 7437155
[No Abstract] [Full Text] [Related]
18. [Studies of the interractions of cyclamate with phenprocomon (author's transl)].
Kinawi A; Baumgartl I
J Clin Chem Clin Biochem; 1977 Jun; 15(6):345-8. PubMed ID: 894206
[TBL] [Abstract][Full Text] [Related]
19. [Anti-coagulant therapy in TIA and cerebral infarct].
Gudmundsson G; Kjellin K; Mettinger KL; Sidén A; Sjöström L; Söderström CE
Lakartidningen; 1980 Dec; 77(52):4956-8. PubMed ID: 7010030
[No Abstract] [Full Text] [Related]
20. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
Weber E; Walter E; Pfleiderer T
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
